XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues        
Product sales $ 1,305,254 $ 561,818 $ 1,950,460 $ 3,373,380
Product sales, related parties 11,709 16,940 32,028 22,940
Manufacturing service revenue 9,049 6,653 22,487 33,248
Kiosk revenue 0 6,824 0 8,890
Total Revenues 1,326,012 592,235 2,004,975 3,438,458
Cost of Sales        
Cost of sales 1,349,631 598,627 2,227,521 2,795,661
Cost of sales, related parties 414,374 0 490,260 0
Total Cost of Sales 1,764,005 598,627 2,717,781 2,795,661
Gross Profit (Loss) from Operations (437,993) (6,392) (712,806) 642,797
Operating Expenses        
General and administrative 1,037,790 791,562 2,770,482 1,758,561
General and administrative, related parties 135,454 45,000 403,963 195,000
Sales and marketing 306,505 200,976 668,227 685,086
Sales and marketing, related parties 29,794 0 79,881 0
Expensing of related party advances and loans 166,267 0 1,487,042 0
Total Operating Expenses 1,675,810 1,037,538 5,409,595 2,638,647
Net Operating Loss (2,113,803) (1,043,930) (6,122,401) (1,995,850)
Other Income (Expense)        
Interest expense (82,109) (3,684) (88,871) (13,080)
Other income and expense (36,977) (1,859) (11,521) (15,109)
Total Other Income (Expense) (119,086) (5,543) (100,392) (28,189)
Net Loss before equity investment (2,232,889) (1,049,473) (6,222,793) (2,024,039)
Share of net losses of equity method investee 28,619 0 28,619 0
Net Loss (2,261,508) (1,049,473) (6,251,412) (2,024,039)
Net loss attributable to non-controlling interests 50,995 617 73,486 2,200
Net Loss Attributable to Hempacco Co., Inc. $ (2,210,513) $ (1,048,856) $ (6,177,926) $ (2,021,839)
Basic and Dilutive Loss per Share $ (0.08) $ (0.05) $ (0.22) $ (0.10)
Shares Used in Calculating Loss per Share 28,524,410 22,468,140 27,575,488 20,670,278